Legal Representation
Attorney
Laura K. Johnson
USPTO Deadlines
Next Deadline
169 days remaining
NOA E-Mailed - SOU Required
Due Date
July 20, 2026
Extension Available
Until January 20, 2027
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 20, 2026 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 25, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 25, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 19, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 23, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 22, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 22, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 22, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 4, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 4, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 4, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 3, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 18, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Aug 18, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 7, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Apr 7, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Small molecule therapeutic pharmaceuticals for the treatment of neurodevelopmental disorders, namely, attention deficit hyperactivity disorder (ADHD), autism spectrum disorders, and Down syndrome
Class 042
Pharmaceutical research and development for neurodevelopment disorders
Additional Information
Design Mark
The mark consists of figures representing molecular models positioned at the top left of the wording "anaka pharma." The first molecular model consists of three purple circles of varying sizes connected by lines. The second model includes three blue circles of different sizes, also connected by lines. The third model has two orange circles of varying sizes connected by a line, with a small purple circle positioned above the figure. The wording "anaka" is in stylized, bold, lower-case black letters, and the wording "pharma" is in smaller, stylized, bold, and thinner lower-case black letters beneath it. The white in the mark is background and is not part of the mark.
Color Claim
The color(s) purple, blue, orange, and black is/are claimed as a feature of the mark.
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
PHARMA